MedTrace Logo

Baby2Home (B2H) Mobile Health Application

NCT05595486 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 642

Last updated 2026-01-06

No results posted yet for this study

Summary

The COVID-19 pandemic has transformed healthcare delivery; arguably, the fields of obstetrics and pediatrics have experienced some of the greatest changes as they have transitioned away from their role as a medical home and into more of an urgent care model of care. Baby2Home is a digital health intervention designed to bridge the resultant gaps in obstetrics and pediatrics healthcare services for new families over the first year of life. This randomized controlled trial will evaluate whether, compared to usual care, Baby2Home 1) improves maternal, paternal, and infant health service utilization outcomes over the first year postpartum, 2) improves maternal and paternal patient reported outcomes, and 3) reduces racial/ethnic and income-based disparities in preventive health services utilization and parental patient reported outcomes.

Conditions

  • COVID-19 Pandemic
  • Health Knowledge, Attitudes, Practice
  • Perinatal Depression
  • Mental Health Wellness
  • Post Partum Depression

Interventions

OTHER

Baby2Home Mobile Application

Baby2Home is a digital health intervention designed to bridge the resultant gaps in obstetrics and pediatrics healthcare services for new families over the first year of life.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Northwestern University

    collaborator OTHER

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Craig Craig, MD · Lurie Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-09
Primary Completion
2025-07-25
Completion
2025-07-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05595486 on ClinicalTrials.gov